Clinical Trials Logo

Clinical Trial Summary

The Hereditary Ataxias are a group of genetic disorders characterized by slowly progressive incoordination of gait and often associated with poor coordination of hands, speech, and eye movements. Current treatments for Hereditary Ataxias are mainly pharmacological, rehabilitative, or psychological treatments,while no effective treatment available. Stem Cell therapy is a novel and promising therapeutic strategy for Hereditary Ataxias treatment. In this study, the safety and efficacy of Human Umbilical Cord Mesenchymal Stem Cells transplantation will be evaluated in patients with Hereditary Ataxias.


Clinical Trial Description

This Study is designed to evaluate the the safety and efficacy of Human Umbilical Cord Mesenchymal Stem Cells transplantation in patients with Hereditary Ataxias. ;


Study Design

Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT01360164
Study type Interventional
Source Shenzhen Beike Bio-Technology Co., Ltd.
Contact Yun Xu
Email xuyun20042001@yahoo.com.cn
Status Recruiting
Phase Phase 1/Phase 2
Start date January 2010
Completion date December 2013

See also
  Status Clinical Trial Phase
Completed NCT00004306 - Clinical and Molecular Correlations in Spinocerebellar Ataxia Type 10 (SCA10) N/A
Completed NCT04750850 - Core Stability Exercises and Hereditary Ataxia N/A
Active, not recruiting NCT06152133 - Telerehabilitation, Core Stability Exercises and Hereditary Ataxia (TRCore-ataxia) N/A
Recruiting NCT05160870 - Genotype-phenotype Correlation and Pathogenic Mechanism in Hereditary Ataxia
Recruiting NCT05160883 - Neuroimaging Changes in Hereditary Ataxia
Completed NCT00202397 - Effect of Riluzole as a Symptomatic Approach in Patients With Chronic Cerebellar Ataxia Phase 2